Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | GMNN | O75496 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | THPO | P40225 | 1/20 | 0.35 |
| ▸ | HBB | P68871 | 1/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11729796 | 0.94 | BBOX1 (0.52) | BBOX1KDM4EMAPTALOX15GMNN | |
| Lithium Ion SCHEMBL17272305 | 0.94 | — | — | |
| SCHEMBL646481 | 0.94 | — | — | |
| SCHEMBL31268422 | 0.94 | BBOX1 (0.52) | BBOX1KDM4EMAPTALOX15GMNN | |
| SCHEMBL10866607 | 0.94 | BBOX1 (0.52) | BBOX1KDM4EMAPTALOX15GMNN | |
| Potassium Ion SCHEMBL1961610 | 0.94 | — | — | |
| Potassium Ion SCHEMBL17272440 | 0.79 | BBOX1 (0.48) | BBOX1KDM4EMAPTALOX15GMNN | |
| Lithium Ion SCHEMBL17272060 | 0.79 | BBOX1 (0.48) | BBOX1KDM4EMAPTALOX15GMNN | |
| SCHEMBL17272288 | 0.79 | BBOX1 (0.48) | BBOX1KDM4EMAPTALOX15GMNN | |
| SCHEMBL17272350 | 0.77 | BBOX1 (0.46) | BBOX1KDM4EMAPTALOX15GMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250051271-A1 | METHOD FOR PREPARING TAURINE, METHYLTAURATE AND METHYLTAURINE SIMULTANEOUSLY | QIANJIANG YONGAN PHARMACEUTICAL CO., LTD. (CN) | 2025-02-13 | — | — | US | claimed |
| EP-4506333-A1 | METHOD FOR PREPARING TAURINE, METHYLTAURATE AND METHYLTAURINE SIMULTANEOUSLY | Qiangjiang Yongan Pharmaceutical Co., Ltd. (CN) | 2025-02-12 | — | — | EP | claimed |
| US-20250051271-A1 | METHOD FOR PREPARING TAURINE, METHYLTAURATE AND METHYLTAURINE SIMULTANEOUSLY | QIANJIANG YONGAN PHARMACEUTICAL CO., LTD. (CN) | 2025-02-13 | — | — | US | disclosed |
| EP-4506333-A1 | METHOD FOR PREPARING TAURINE, METHYLTAURATE AND METHYLTAURINE SIMULTANEOUSLY | Qiangjiang Yongan Pharmaceutical Co., Ltd. (CN) | 2025-02-12 | — | — | EP | disclosed |
| EP-1928402-B1 | Carnitine derivative, salt thereof, external skin preparation and cosmetic preparation | SHOWA DENKO KK (JP) | 2014-03-12 | — | — | EP | disclosed |
| US-8551509-B2 | Skin agent for external use and cosmetic agent including ubiquinone derivative or salt thereof and method using the same | SHOWA DENKO K.K. (JP) | 2013-10-08 | — | — | US | disclosed |
| US-20110144062-A1 | DERMATOLOGICAL ANTI-WRINKLE AGENT | SHOWA DENKO K.K. (JP) | 2011-06-16 | — | — | US | disclosed |
| US-7842726-B2 | Carnitine derivative, salt thereof, external skin preparation and cosmetic material | SHOWA DENKO K.K. (JP) | 2010-11-30 | — | — | US | disclosed |
| EP-1912708-B1 | EMULSIFIED SKIN EXTERNAL PREPARATION AND METHOD FOR STABILIZING THE SKIN EXTERNAL PREPARATION | SHOWA DENKO KK (JP) | 2010-09-08 | — | — | EP | disclosed |
| US-20100152139-A1 | EMULSIFIED SKIN EXTERNAL PREPARATION AND METHOD FOR STABILIZING THE SKIN EXTERNAL PREPARATION | SHOWA DENKO K.K. (JP) | 2010-06-17 | — | — | US | disclosed |
| US-20100152134-A1 | EMULSIFIED SKIN EXTERNAL PREPARATION AND METHOD FOR STABILIZING THE SKIN EXTERNAL PREPARATION | SHOWA DENKO K.K. (JP) | 2010-06-17 | — | — | US | disclosed |
| EP-1981492-A1 | WHITENING DERMATOLOGICAL PREPARATIONS | Showa Denko K.K. (JP) | 2008-10-22 | — | — | EP | disclosed |
| WO-2008047882-A1 | SKIN AGENT FOR EXTERNAL USE AND COSMETIC AGENT INCLUDING UBIQUINONE DERIVATIVE OR SALT THEREOF AND METHOD USING THE SAME | SHOWA DENKO K.K. (JP) | 2008-04-24 | — | — | WO | disclosed |
| EP-1912708-A1 | EMULSIFIED SKIN EXTERNAL PREPARATION AND METHOD FOR STABILIZING THE SKIN EXTERNAL PREPARATION | Showa Denko K.K. (JP) | 2008-04-23 | — | — | EP | disclosed |
| EP-1909917-A1 | EMULSIFIED SKIN EXTERNAL PREPARATION AND METHOD FOR STABILIZING THE SKIN EXTERNAL PREPARATION | Showa Denko K.K. (JP) | 2008-04-16 | — | — | EP | disclosed |
| WO-2008001921-A2 | DERMATOLOGICAL ANTI-WRINKLE AGENT | SHOWA DENKO K.K. (JP) | 2008-01-03 | — | — | WO | disclosed |
| WO-2007091694-A1 | WHITENING DERMATOLOGICAL PREPARATIONS | SHOWA DENKO K.K. (JP) | 2007-08-16 | — | — | WO | disclosed |
| WO-2007043339-A9 | CARNITINE DERIVATIVE, SALT THEREOF, EXTERNAL SKIN PREPARATION AND COSMETIC MATERIAL | SHOWA DENKO KK (JP) | 2007-06-07 | — | — | WO | disclosed |
| WO-2007013634-A1 | EMULSIFIED SKIN EXTERNAL PREPARATION AND METHOD FOR STABILIZING THE SKIN EXTERNAL PREPARATION | SHOWA DENKO K.K. (JP) | 2007-02-01 | — | — | WO | disclosed |
| WO-2007013633-A1 | EMULSIFIED SKIN EXTERNAL PREPARATION AND METHOD FOR STABILIZING THE SKIN EXTERNAL PREPARATION | SHOWA DENKO K.K. (JP) | 2007-02-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152134-A1 | EMULSIFIED SKIN EXTERNAL PREPARATION AND METHOD FOR STABILIZING THE SKIN EXTERNAL PREPARATION | DEGS1, DSG1, TTPA | BBOX1 2475/4885KDM4E 2019/4885MAPT 3584/4885 |
| US-20100152139-A1 | EMULSIFIED SKIN EXTERNAL PREPARATION AND METHOD FOR STABILIZING THE SKIN EXTERNAL PREPARATION | CUTA, LIPA, ASAH1 | BBOX1 3609/4885KDM4E 3418/4885MAPT 4443/4885 |
| US-20110144062-A1 | DERMATOLOGICAL ANTI-WRINKLE AGENT | CUTA, COL1A1, GLA | BBOX1 2276/4885KDM4E 564/4885MAPT 2399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.